Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
48.74
+0.69 (1.44%)
At close: Aug 13, 2025, 4:00 PM
49.00
+0.26 (0.53%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Sanofi Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Sanofi stock has a target of 65, which predicts a 33.36% increase from the current stock price of 48.74.
Price Target: $65.00 (+33.36%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Aug 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $65 | Hold | Initiates | $65 | +33.36% | Mar 21, 2025 |
| Argus Research | Argus Research | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +23.10% | Jul 26, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $55 | Hold | Initiates | $55 | +12.84% | Jan 23, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +23.10% | Mar 27, 2023 |
Financial Forecast
Revenue This Year
45.55B
from 44.29B
Increased by 2.85%
Revenue Next Year
48.58B
from 45.55B
Increased by 6.65%
EPS This Year
8.32
from 4.44
Increased by 87.41%
EPS Next Year
9.13
from 8.32
Increased by 9.67%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 51.3B | 54.5B | 56.9B | ||
| Avg | 45.5B | 48.6B | 51.3B | ||
| Low | 42.0B | 44.7B | 46.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.8% | 19.7% | 17.1% | ||
| Avg | 2.9% | 6.6% | 5.7% | ||
| Low | -5.1% | -2.0% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.04 | 9.92 | 10.95 | ||
| Avg | 8.32 | 9.13 | 9.72 | ||
| Low | 7.60 | 8.11 | 8.45 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 103.6% | 19.2% | 20.0% | ||
| Avg | 87.4% | 9.7% | 6.5% | ||
| Low | 71.1% | -2.5% | -7.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.